EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Smoking, GAD65 autoimmunity, genetic susceptibility to type 1 diabetes and incident adult-onset diabetes in the EPIC-InterAct case–cohort study

Emmy Keysendal iD, Sofia Carlsson iD, Anna-Maria Lampousi iD, Christiane S Hampe iD, José M Huerta iD, Nicola Kerrison iD, Peter M Nilsson iD, Valeria Pala iD, Matthias B Schulze iD, Stephen J Sharp iD, Olov Rolandsson iD, Nicholas J Wareham iD

Metabologia · 2026

DOI: 10.1007/s44357-026-00003-9 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Metabologia, 2026. Verfasst von Emmy Keysendal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Svenska Diabetesstiftelsen, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Smoking increases the risk of type 2 diabetes, but its role in autoimmune diabetes remains unclear. We investigated whether smoking is associated with being GAD65 autoantibody (GAD65Ab) positive or the risk of progressing to diabetes. We also assessed its interaction with genetic susceptibility to type 1 diabetes.

Methods

We used data from the EPIC-InterAct case–cohort study including 11,161 incident cases of adult-onset diabetes and 14,922 subcohort participants. Logistic regression was used to estimate odds ratios (ORs) for being GAD65Ab positive at baseline by smoking status. Hazard ratios (HRs) of diabetes by baseline smoking and GAD65Ab status were estimated using Prentice-weighted Cox regression. Two- and three-way interactions between smoking, GAD65Ab status and a type 1 diabetes genetic risk score (T1D-GRS) were assessed by attributable proportion due to interaction (AP).

Results

There was no evidence that smoking was associated with being GAD65Ab positive (OR 1.00, 95% CI 0.82, 1.22 current vs never smoking), but among GAD65Ab-positive participants current smokers were more likely to progress to diabetes than never smokers (HR 1.40, 95% CI 1.03, 1.90) and there was an interaction between being GAD65Ab positive and heavy smoking for diabetes risk (AP 0.32, 95% CI 0.15, 0.49 ≥ 15 pack-years vs never smoking). Three-way interaction between heavy smoking, being GAD65Ab positive and the highest T1D-GRS tertile was also observed (combined HR 7.30, 95% CI 5.17, 10.31; AP 0.46, 95% CI 0.23, 0.70). Conclusions/interpretation While smoking may not be associated with being GAD65Ab positive, it may increase the risk of progressing to diabetes in GAD65Ab-positive individuals and in those with genetic susceptibility to type 1 diabetes. Graphical Abstract

Schlagwörter

Stichwörter der Autor:innen

DiabetesGAD65AbGenetic susceptibilityInteractionSmoking

Autor:innen und Institutionen

  • Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medicine, University of Washington School of Medicine, Seattle, WA USA.
  • Department of Epidemiology, Murcia Regional Health Council-IMIB, Murcia, Spain.
  • CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Medical Research Council Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Department of Clinical Sciences, Clinical Research Center, Skåne University Hospital, Lund University, Malmö, Sweden.

ORCID-Profile: Emmy Keysendal, Sofia Carlsson, Anna-Maria Lampousi, Christiane S Hampe, José M Huerta, Nicola Kerrison, Peter M Nilsson, Valeria Pala, Matthias B Schulze, Stephen J Sharp, Olov Rolandsson, Nicholas J Wareham

Förderung

  • Vetenskapsrådet
  • Svenska Diabetesstiftelsen
  • National Institutes of Health
  • Umeå Universitet
  • Medical Research Council
  • Karolinska Institute

Zitieren

APA

Keysendal, E., Carlsson, S., Lampousi, A. M., Hampe, C. S., Huerta, J. M., Kerrison, N., Nilsson, P. M., Pala, V., Schulze, M. B., Sharp, S. J., Rolandsson, O., & Wareham, N. J. (2026). Smoking, GAD65 autoimmunity, genetic susceptibility to type 1 diabetes and incident adult-onset diabetes in the EPIC-InterAct case–cohort study. Metabologia. https://doi.org/10.1007/s44357-026-00003-9

Vancouver

Keysendal E, Carlsson S, Lampousi AM, Hampe CS, Huerta JM, Kerrison N, et al. Smoking, GAD65 autoimmunity, genetic susceptibility to type 1 diabetes and incident adult-onset diabetes in the EPIC-InterAct case–cohort study. Metabologia. 2026. doi:10.1007/s44357-026-00003-9

BibTeX
@article{Keysendal2026,
  author = {Keysendal, Emmy and Carlsson, Sofia and Lampousi, Anna-Maria and Hampe, Christiane S and Huerta, José M and Kerrison, Nicola and Nilsson, Peter M and Pala, Valeria and Schulze, Matthias B and Sharp, Stephen J and Rolandsson, Olov and Wareham, Nicholas J},
  title = {Smoking, GAD65 autoimmunity, genetic susceptibility to type 1 diabetes and incident adult-onset diabetes in the EPIC-InterAct case–cohort study},
  journal = {Metabologia},
  year = {2026},
  doi = {10.1007/s44357-026-00003-9}
}
Kostenlos starten →